Introduction
Lung transplantation is a valuable therapeutic option for patients with end-stage lung diseases. The major obstacle limiting lung transplant survival and function is chronic lung allograft dysfunction (CLAD), with one of the major manifestations being obliterative bronchiolitis (OB) with fibrous obliteration of the airways (1) . Progressive airway injury mediated by ongoing alloimmune and nonalloimmune responses to the lung allograft is thought to be the precursor of subsequent graft fibrosis (2) . OB/BOS remains one of the major limitations to long term success of lung transplant with approximately 50% of lung transplant recipients affected by 5 years (3).
Recently, IL-17 and T helper 17 (Th17) cells have been linked to OB/BOS development after lung transplantation (4) . Expression of IL-17 in the BAL positively correlated with OB in lung transplant recipients and Th17 cells were associated with OB/BOS in humans (5, 6) . Using a murine MHC minor mismatch orthotopic lung transplantation model, our group previously found that systemic IL-17A protein and mRNA levels were much higher in mice with OB compared to those without OB (7) . Furthermore, mice treated with an IL-17RA:Fc fusion protein had decreased cellular rejection scores and did not develop OB. However, the cellular sources of IL-17A in OB have not been investigated in an intact orthotopic lung transplant model. A major source of IL-17 is CD4 + T cells (Th17), but other cells are known to produce IL-17A including innate lymphocytes (8) (9) (10) (11) .
In the present study, we have investigated the source and timing of IL-17A producing cells and their requirement to promote graft fibrosis and OB. We reasoned that identifying particular subsets may allow the design of more targeted and effective therapies that have less unintended consequences. Our results suggest CD4 + T cells are required for promoting the IL-
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17A response to transplant and the development of OB in this model. In contrast, deficiency of either major IL-17A-producing subset, Th17 or γδ T cells alone is not sufficient to prevent airway fibrosis. Each subset may be compensating for the lack of the other to produce IL-17 and induce airway fibrosis. .CD4-Cre (STAT3 CD4-/-) mice were previously described (12, 13) . C57Bl/6J.TCRδ -/-mice were purchased from Jackson Laboratories (Bar Harbor, ME).
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Materials and Methods
Animals
Mice were housed under specific pathogen-free conditions in the animal care facility at Indiana University or University of Illinois at Chicago. Male animals weighing 24-30g were used as both donors and recipients. All experimental mouse protocols were reviewed and approved by the Indiana University School of Medicine and the University of Illinois at Chicago Institutional
Animal Care and Use Committee
Orthotopic lung transplant
A mouse model of orthotopic minor histocompatibility antigen mismatch left lung transplant was used and has been previously described in detail (7) .
CD4 T cell depletion in vivo
CD4
+ T cells were depleted in vivo by injection of rat anti-mouse CD4 (GK1.5) monoclonal antibody (Bio-X-cell), 250 µg on days -2, 0 and twice per week after transplantation. Untreated allografts or isotype treated wild-type recipients were used as controls.
Histology
Lungs were inflated via the trachea with 10% neutral buffered formalin solution (Sigma-Aldrich, Missouri, USA), followed by embedding in paraffin. Tissue sections were prepared and stained with H&E or Masson's trichrome stain. Standard clinical criteria for scoring vascular lung rejection were used according to ISHLT guidelines and scoring was done blinded (14) . For the 7 17A producing CD4  + T cells and IFNγ producing CD4  + and CD8  + T cells infiltrate lung allografts A minor mismatch model of orthotopic left lung transplantation using C57Bl/10 (B10) mice as donors and C57Bl/6 (B6) mice as recipients was used as previously described (7) . To further characterize the immune response to transplant in this model, we determined the frequency of CD4 + and CD8 + T cells infiltrating the lung at different time-points after transplant.
Results
IL-
On day 7 post-transplant, very few lymphocytes had infiltrated the lungs and the production of cytokines was minimal (data not shown). Compared to B6→B6 syngeneic lung transplants, CD4 + and CD8 + T cells were increased at day 21 in B10→B6 lung allografts ( Figure S1 ). By day 28 post-transplant, the frequency of CD4 + and CD8 + T cells in the lung allografts was comparable to the syngeneic lung transplants.
CD4
+ T cells were found to be either IFN-γ + or IL-17A + and the frequency of both subsets of cytokine-producing cells was increased compared to syngeneic grafts peaking at Day 21 ( Figure 1A and B). The frequency of IFN-γ + CD8 + T cells was also significantly increased in lung allografts and peaked at day 21 ( Figure 1C and D) . Very few CD8 + T cells produced IL-17A in either allografts or syngeneic grafts ( Figure 1C ). However, the percentage of IL-17A + cells was not completely accounted for by CD4 + T cells ( Figure 1E ). Both IL-17A producing CD4 + and CD4-negative lymphocytes contributed to an increased frequency of IL-17A + lymphocytes in lung allografts.
γδ T cells and CD4 + T cells are the majority of IL-17A + cells in allografts
We found that γδ T cells were the other major population of IL-17A producing lymphocytes in B10→B6 lung allografts ( Figure 2A ). In B6→B6 syngeneic grafts, they were 8 the majority of IL-17A + lymphocytes, as well as in the native right lungs ( Figure 2A and data not shown). In addition to CD4 + T cells and γδ T cells, we found a small proportion of non-T cells producing IL-17A, which were not NK cells, and are likely innate lymphoid cells (ILC) ( Figure   S2 ). Among IL-17A + TCRβ + T cells, CD4 + T cells were the majority of cells followed by CD4 -CD8 -T cells ( Figure S2 ). CD8 + , NK1.1 + or invariant NK T cells were not a major proportion of the IL-17A + cells ( Figure S2 ).
The absolute number of total IL-17A + lymphocytes was significantly increased only in B10→B6 allografts and not B6→B6 syngeneic grafts ( Figure 2B ). In addition, the absolute numbers of IL-17A + CD4 + T cells and IL-17A + γδ T cells were significantly higher in the allografts ( Figure 2B ). The total number of γδ T cells was also significantly increased in allografts compared with syngeneic grafts ( Figure 2B ). These data suggested that both CD4 + and γδ T cells were the major sources of IL-17A after lung transplant.
Depletion of CD4 + T cells prevents chronic rejection and OB and affects expansion of IL-17A
+ cells
To determine if CD4 + T cells were necessary for cellular rejection and airway fibrosis after orthotopic lung transplant, recipient mice were treated with a CD4-depleting antibody. On day 21 after transplant, allografts from CD4-depleted mice displayed a normal gross appearance, while untreated control allografts were grossly darker in color and shrunken in size (data not shown). Remarkably, none of the CD4-depleted allografts developed OB, while 44% of control allografts developed OB-like lesions, a similar incidence to what was reported previously (7) ( Table 1 ). Based on established clinical rejection criteria, we observed either no acute rejection 
STAT3 signaling in CD4 + T cells and Th17 are not required for OB development
While CD4 + T cells were required for the cellular rejection and airway fibrosis in our model, we hypothesized that Th17 cells were the key CD4 + T cells for driving the rejection response. STAT3 is the major transcription factor required for the initiation of Th17 differentiation (12, 16, 17 Figure 5C ). The incidence of OB in the littermate controls was 1 out of 10 (10%). Acute rejection scores in these mice were also comparable to the left lung allografts from littermate controls ( Figure 5D ). There was no difference in the overall fibrosis scores between the STAT3 CD4-/-mice and controls ( Figure 5D ). (16, 20) . As expected, we found a significantly higher proportion of IFNγ + CD4 + T cells in the STAT3 CD4-/-allografts as compared to WT allografts ( Figure S4 ). However, the absolute number of IFNγ + CD4 + T cells remained similar between STAT3 CD4-/-and WT allografts ( Figure S4 ). Expression of IFNγ, TGF-β, IL-6 and IL-10 were also not altered in STAT3
CD4-/-allografts ( Figure S4 ).
IL-17A production by γδ T cells in the absence of Th17
Since airway fibrosis and OB developed in the left lung allografts in STAT3 CD4-/-mice, 
γδ T cells are not necessary for OB development
Our data suggested that γδ T cells may participate in OB development through production of IL-17A. Earlier studies found that γδ T cell deficiency was associated with prolonged survival of cardiac allografts (22, 23) . To determine whether γδ T cells were required for OB development, TCRδ -/-mice were used as recipients. However, there was no apparent effect on cellular rejection or fibrosis in the absence of γδ T cells ( Figure 7A and B). TCRδ -/-recipients developed OB-like lesions similar to TCRδ +/-controls with 3 out of 11 TCRδ -/-mice (27.2%)
developing OB compared to 2 of 8 mice (25%) developing OB in the controls. In the absence of γδ T cells, the majority of IL-17A + cells were CD4 + T cells in the lung allografts and the native lungs ( Figure 7C ). At the time of sacrifice, we did not find evidence of residual donor γδ T cells in the lungs (data not shown). As with the STAT3 CD4-/-mice, TCRδ -/-allografts had a frequency of IL-17A + cells similar to WT recipients ( Figure 7D ). These data suggest IL-17A production is compensated for by CD4 + T cells in the absence of γδ T cells and γδ T cells are not absolutely required for cellular rejection and the development of OB in this model.
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DISCUSSION
In the current study, we investigated the requirement for IL-17 producing T cells to mediate chronic rejection and the development of OB in a mouse lung transplant model previously found to be ameliorated by IL-17 neutralization (7). We found that CD4 + T cells expression in γδ T cells (27) . However, we were surprised to find an intact IL-17A γδ T cell response in the absence of Th17 cells, as a recent study suggested that Th17 cells were required for the maintenance of IL-17-producing γδ T cells in vivo in a TGF-β dependent manner (21) .
Instead, we found that γδ T cells from the lungs or draining lymph nodes had no defect in IL-17A production either in un-manipulated mice (unpublished data) or after transplant in the absence of Th17. It is possible STAT3 CD4-/-T cells produce enough TGF-β to support maintenance of IL-17A + γδ T cells during homeostasis.
In the TCRδ -/-recipients, we found that fibrosis and OB was not decreased compared to controls. We did not use antibody depletion of γδ T cells, as the antibodies have been found to be non-depleting in vivo and may be activating γδ T cells (28, 29) . However, we did not find residual γδ T cells to suggest expansion of donor γδ T cells was confounding our results. appear to be able to respond to deficiency of other subsets.
Interestingly, we found differences in the prevalence of OB-like pathology in wild-type littermates of STAT3 CD4-/-mice, bred in house on a C57Bl/6N background, compared to mice purchased from Harlan Labs. The previous study with this model found a similar incidence of OB, also using C57Bl/6N mice from Harlan Labs (7). However, a recent study did not find evidence of OB using C57Bl/10 lung transplanted to C57Bl/6J mice from Jackson labs (30) . We also found the TCRδ -/-mice from Jackson and TCRδ +/-mice, mixed C57Bl/6N and C57Bl/6J background, had a decreased incidence of OB at 25%, although we still found similar pathology to the previous study (7) . The different results may be due to differences in microbiota or differences in genetic background between the strains. Procedural and technical variations also cannot be ruled out. An important caveat in our model is that the airway fibrosis pattern differs from the constrictive OB that can be found in humans after lung transplant. The pathology in our model includes fibrous plugs, with loss of overlying epithelium and only partial airway obliteration (7, 31) . Nevertheless, the model allows an understanding of the processes by which the alloreactive immune response and IL-17A can promote fibrosis after lung transplant without the need for immunosuppression as in a full mismatch model (32) .
Previously it was found that blockade of IL-17 using IL-17R:Fc protein abrogated OB Frequency of IL-17A + lymphocytes in transplanted left lungs from wild-type mice (n=7) as in Figure 4 and TCRδ -/-mice.
Supporting information
Additional Supporting Information may be found in the online version of this article. 
Orthotopic lung transplant
A mouse model of orthotopic minor histocompatibility antigen mismatch left lung transplant was used and has been previously described in detail (10) . The entire operation was performed using a Prescott's operating microscope (Zeiss 6SFC, Monument, USA) with 20-40× magnification.
All surgical procedures were performed utilizing sterile technique. Mice were not treated with antibiotics or immunosuppressive agents. Both donor and recipient were anesthetized with Isoflurane.
Histology
Lungs were inflated via the trachea with 10% neutral buffered formalin solution (Sigma-Aldrich, Missouri, USA), followed by embedding in paraffin. Tissue sections were prepared and stained with H&E or Masson's trichrome stain. Standard clinical criteria for scoring vascular lung rejection were used according to ISHLT guidelines and scoring was done blinded (17). For the severity of fibrosis an arbitrary scale was used with F1= normal; F2= mild fibrosis, F3= moderate fibrosis, F4=severe fibrosis (18) . Presence of OB lesions was also determined. For transplanted lungs, 2/3 of the lung was used for histology and the remaining 1/3 was used for flow cytometry. As a control, the upper and middle lobes from the native right lungs were used for histology or flow cytometry.
Flow cytometry
For cell surface staining, cells were stained with antibodies for CD4, CD8, TCRβ, TCR γδ, and NK1.1 in FACS buffer (0.01% NaN 3 + 2% FBA in 1X PBS) for 30 min at 4°C. Cells were stained with PBS57-loaded CD1d tetramer (NIH Tetramer facility, Emory University) for identification of invariant NKT (iNKT) cells. For staining of intracellular cytokines, cells were stained with surface markers, fixed with 2% formaldehyde and permeabilized with 0.5% saponin buffer. After permeabilization, cells were stimulated with PMA (100 ng/ml; Sigma), ionomycin
(1 μg/ml; Sigma) for 4 hours and Brefeldin A (10 µg/ml; Sigma) was added for last 3 hours.
Cells were then stained with antibodies for IL-17A, IFN-γ and respective isotype controls. The stained cells were acquired on a LSRII (BD Biosciences) and data analysis was performed with
Flowjo software (Tree Star, Ashland, OR). The absolute number of cells has been adjusted for the weight of the lung tissue, as only a portion of lung is used for flow cytometry. All antibodies were obtained from BioLegend.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 5.0 (GraphPad Software, San Diego, CA). For comparison of two groups with normal distribution, two-tailed unpaired t test was used. One-way ANOVA with post hoc Newman-Keuls test was applied for comparisons between multiple groups with normal distribution. For skewed data, Mann-Whitney U test was applied. The prevalence of OB between different groups in Table 1 was compared using twotailed Fisher's exact test. Differences were considered significant at P<0.05. All data are expressed as mean ± (SEM).
